| Click Here to receive daily reports of the TOP PICKS OR your personal stock choices | STOCKCHASEWhat the experts are saying! |
| There are 7 registered members and 84 guests viewing the site. | Follow us on Twitter | Rss Top Picks Feed | Rss Daily Feed |
|
| WATCH | 0.450 | Peter Hodson | WEX Pharmaceutical recently failed its trials. The company now has to regroup and decide what to do next. It is a long process to rebuild. The vice-president stepped down as well recently. Recommends looking at how much cash the company has before entering. | 2006-03-09 | |
| WAIT | 2.000 | Rob Peets | In phase 2 clinical trials in Canada andChina. Trading in a $2/2.50 range. In current negotiations. | 2002-10-22 |